Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

AGN's Microdose / sub hallucinogenic DMT pre clinical work completed by Charles River Labs.
UK MHRA clinical trial applications filed Jan 2022
GMT DMT produced.
Hammerschmidt to run the Phase 1 CT and experts hired for planning and participation in Phase 2 ...

5 year timeline for the Ninion's, R+D and pre clinical work...

https://ir.algernonpharmaceuticals.com/news-events/press-releases/detail/5/algernon-pharmaceuticals-completes-manufacturing-of
"Anthony Rudd, MB, BChir, FRCP, CBE is an emeritus professor of Stroke Medicine at Kings College London and recently retired as a consultant stroke physician at Guy’s and St Thomas’ Hospital. He was the London Stroke Clinical Director from 2010-2019 and the National Clinical Director for Stroke for NHS England from 2013-2019, where he oversaw dramatic improvements in the paradigm of NHS stroke treatment."
"Dr. Robert Simister

Robert Simister MA MB BS PhD FRCP is a consultant neurologist and stroke physician as well as an honorary senior lecturer at University College London, where he also serves as the Clinical Lead for the Comprehensive Stroke Service and the Clinical Director of Stroke Medicine and Acute Neurology. Since 2019, he has been the Joint Clinical Director for the London Stroke Clinical Network."

https://ir.algernonpharmaceuticals.com/news-events/press-releases/detail/10/algernon-announces-positive-feedback-on-its-planned-phase


...GLTA...